有価証券レコード · アーカイブ済み四半期
IONS
Ionis Pharmaceuticals, Inc. · Healthcare · Biotechnology
17追跡対象保有者
—Δ保有者数
24.68M保有株数
$1.18B報告済み評価額
+0新規ポジション
−0解消銘柄
すべての保有状況データ：追跡対象13Fマネージャーのみ、普通株ポジション、報告期間 Q2 2024
保有状況の推移
| 四半期 | 保有者 | Δ | 株数 | 報告済み評価額 | 新規 | 解消銘柄 |
|---|---|---|---|---|---|---|
| Q2 2026 | 139 | +2 | 148.59M | $11.08B | +6 | −3 |
| Q1 2026 | 139 | -2 | 142.62M | $9.86B | +6 | −9 |
| Q4 2025 | 142 | 0 | 143.10M | $10.36B | +1 | — |
| Q3 2025 | 25 | +4 | 95.56M | $6.25B | +5 | −2 |
| Q2 2025 | 19 | +1 | 95.25M | $3.76B | +1 | — |
| Q1 2025 | 15 | -1 | 43.90M | $1.32B | +1 | −2 |
| Q4 2024 | 16 | -1 | 43.25M | $1.51B | — | −1 |
| Q3 2024 | 16 | -1 | 34.86M | $1.40B | — | −1 |
| Q2 2024 | 17 | — | 24.68M | $1.18B | — | — |
保有者情報 · Q2 2024
| # | 運用会社 | 株数 | Δ株式数 | 時価 | そのウェイト | 保有中 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 6.57M | — | $313.07M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 6.57M | — | $313.07M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 6.57M | — | $313.07M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 6.57M | — | $313.07M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 6.57M | — | $313.07M | 0.1% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 6.57M | — | $313.07M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 6.57M | — | $313.07M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 6.57M | — | $313.07M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 6.57M | — | $313.07M | 0.1% | n/c | 1 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 3.93M | — | $187.51M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 3.93M | — | $187.51M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Tweedy, Browne ✦ | 3.45M | — | $164.65M | 7.6% | n/c | 1 | SEC ↗ |
| 13 | Geode Capital Management ✦ (パッシブ) | 2.48M | — | $118.45M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Geode Capital Management ✦ (パッシブ) | 2.48M | — | $118.45M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Capital World Investors ✦ | 2.25M | — | $107.33M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | ARK Investment Management ✦ | 1.36M | — | $64.87M | 0.6% | n/c | 1 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 1.03M | — | $49.00M | 0.1% | n/c | 1 | SEC ↗ |
| 18 | Norges Bank ✦ (パッシブ) | 1.02M | — | $48.58M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Adage Capital Partners ✦ | 800.00K | — | $38.13M | 0.1% | n/c | 1 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 627.03K | — | $29.88M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 627.03K | — | $29.88M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Citadel Advisors ✦ | 627.03K | — | $29.88M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Citadel Advisors ✦ | 627.03K | — | $29.88M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Baillie Gifford ✦ | 260.25K | — | $12.40M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Baillie Gifford ✦ | 260.25K | — | $12.40M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Baillie Gifford ✦ | 260.25K | — | $12.40M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Renaissance Technologies ✦ | 249.51K | — | $11.89M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | D. E. Shaw & Co. ✦ | 190.78K | — | $9.09M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | D. E. Shaw & Co. ✦ | 190.78K | — | $9.09M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Marshall Wace ✦ | 173.20K | — | $8.25M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Marshall Wace ✦ | 173.20K | — | $8.25M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Point72 Asset Management ✦ | 137.21K | — | $6.54M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Millennium Management ✦ | 128.22K | — | $6.11M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Gotham Asset Management ✦ | 6.26K | — | $298,447 | 0.0% | n/c | 1 | SEC ↗ |
「当該ウェイト」= そのマネージャーの報告済み13F株式評価額に占めるポジションの割合（確信度の指標）。✦ = キュレーション済みマネージャー。
新規買い手
| 今四半期は新規追跡買い手がいません。 |
ポジション解消済み
| 今四半期は追跡されたエグジットがありません。 |
市場全体のコンテキスト: 全13Fファイラー対象（SEC構造化データ、 Q1 2026): 490 保有者, 170.17M 株式数, $11.94B 報告済み. これは上記の追跡対象ユニバースの数値とは異なる、より古い期間のものであり、両者が混在することはありません。
共同保有が多い銘柄
この有価証券の追跡対象保有者が最も頻繁に保有する他の銘柄 — ファンダメンタルな関係ではなく、共同保有件数に基づきます。